Top Markets
#1 Siren Siren +34.93%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.13%
#3 Cysic Cysic +18.09%
#4 PulseChain PulseChain +18.03%
#5 Ribbita by Virtuals Ribbita by Virtuals +17.74%
#6 TROLL TROLL +17.09%
#7 KUB Coin KUB Coin +15.67%
#8 OpenEden OpenEden +15.56%
#9 BasedHype BasedHype +14.48%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.44%
Coin of the day
Siren Siren
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Pozycja w akcjach #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Cena akcji
$0.4018
Kapitalizacja rynkowa
$14.12M
Zmiana (1 dzień)
-3.20%
Zmiana (1 rok)
-88.15%
Kraj
US
Handel Skye Bioscience, Inc. (SKYE)

Kategoria

Healthcare
Historia stopy dywidendy dla Skye Bioscience, Inc. (SKYE)
Stopa dywidendy (TTM) dla Skye Bioscience, Inc. (symbol akcji: SKYE) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Skye Bioscience, Inc. (SKYE) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE